Adam Fine

Adam Fine is a co-founder and CEO of Windham Venture Partners. Adam is currently Director at GlySens, CuraSeal and HelpAround, Board Observer to SpineView, MC10, Holaira and VytronUS. Adam is a mentor in Blueprint Health, a healthcare IT accelerator in NYC. Prior to Windham, Adam was VP & GM at I-many, Inc., an enterprise software company. Prior to joining I-many, Adam was a New Business Development Analyst at Cordis Corporation, a Johnson & Johnson company focused on interventional vascular devices such as stents. In that capacity, Adam worked on a range of licenses, acquisitions, divestments, as well as strategic investments with Johnson & Johnson Development Corporation (JJDC), J&J’s strategic venture arm. Prior to J&J, Adam was a research analyst at Coopers & Lybrand’s Integrated Healthcare Consulting practice.

Adam Fine is the Co-Founder, General Partner & CEO at Windham Venture Partners, based in New York, New York, United States, North America. With a background in Financial Services, Adam Fine has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.